Your browser doesn't support javascript.
loading
A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors.
Mettu, Niharika B; Ulahannan, Susanna V; Bendell, Johanna C; Garrido-Laguna, Ignacio; Strickler, John H; Moore, Kathleen N; Stagg, Robert; Kapoun, Ann M; Faoro, Leonardo; Sharma, Sunil.
Afiliación
  • Mettu NB; Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina.
  • Ulahannan SV; Department of Internal Medicine, Hematology-Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Bendell JC; Drug Development Unit, Sarah Cannon Research Institute at Tennessee Oncology, Nashville, Tennessee.
  • Garrido-Laguna I; Drug Development Unit, Sarah Cannon Research Institute at Tennessee Oncology, Nashville, Tennessee.
  • Strickler JH; Department of Internal Medicine, Utah School of Medicine, Salt Lake City, Utah.
  • Moore KN; Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina.
  • Stagg R; Department of Internal Medicine, Hematology-Oncology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Kapoun AM; OncoMed Pharmaceuticals/Mereo BioPharma, Redwood City, California.
  • Faoro L; OncoMed Pharmaceuticals/Mereo BioPharma, Redwood City, California.
  • Sharma S; OncoMed Pharmaceuticals/Mereo BioPharma, Redwood City, California.
Clin Cancer Res ; 28(5): 882-892, 2022 Mar 01.
Article en En | MEDLINE | ID: mdl-34844977

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Exantema Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Primarias Secundarias / Exantema Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos